Rentokil Initial plc (NYSE:RTO – Get Free Report) has received an average recommendation of “Moderate Buy” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $29.00.
RTO has been the subject of a number of recent analyst reports. Citigroup upgraded Rentokil Initial to a “strong-buy” rating in a research report on Friday, December 13th. Redburn Atlantic cut shares of Rentokil Initial from a “buy” rating to a “neutral” rating in a research report on Thursday, September 19th.
View Our Latest Analysis on RTO
Hedge Funds Weigh In On Rentokil Initial
Rentokil Initial Stock Down 1.9 %
Shares of RTO stock opened at $25.55 on Thursday. The stock has a 50 day simple moving average of $25.53 and a 200 day simple moving average of $27.83. Rentokil Initial has a 1 year low of $22.40 and a 1 year high of $34.07. The company has a current ratio of 1.04, a quick ratio of 0.96 and a debt-to-equity ratio of 0.75.
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
See Also
- Five stocks we like better than Rentokil Initial
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- When to Sell a Stock for Profit or Loss
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.